8 The low temperature factor (ca. 20 Å) is another indication that only
a single conformation of the benzylammonium ion is present in the
binding pocket. Interestingly, molecular dynamics simulations on the
benzylammonium–trypsin complex showed two different conforma-
tions of benzylammonium in the pocket. One exactly matches the
electron density map of the benzylammonium–trypsin crystals and
the other forms two hydrogen bonds with the carbonyl oxygen of
Ser190 and Asp189 OG2.
9 Since the pKa of benzylammonium is 9.5 at pH 8.0 (C. H.
Arrowsmith, H.-X. Guo and A. J. Kresge, J. Am. Chem. Soc.,
1994, 116, 8890–8894), the pH at which the measurements are
performed, 3.1% of the ammonium group is deprotonated, which
is not considered significant. The percentage was calculated using
the Henderson–Hasselbalch equation (A. Fersht, Structure and
Mechanism in Protein Science, Freeman, New York, 1999):
used. A 2 M solution of Me3Al in toluene (15.3 ml, 30.5 mmol)
was slowly added to a magnetically stirred suspension of 1.8 g
(33 mmol) of NH4Cl in 14 ml of toluene (suspension dried by
azeotropic distillation to 14 ml of 27 ml of toluene under a N2
atmosphere) at 0 °C under a N2 atmosphere. After the addition,
the mixture was warmed to 25 °C and stirred until the gas evolu-
tion had ceased. Cyclohexylcarbonitrile (2.0 g, 18 mmol) was
added and the solution was heated to 80 °C under a nitrogen
atmosphere until TLC indicated the absence of nitrile. The reac-
tion mixture was slowly poured into a slurry of 10 g silica gel in
30 ml of chloroform and stirred for 5 min. Next, 25 ml methanol
was added and the suspension was stirred for 2 h. The silica was
filtered off and washed with methanol. The filtrate and wash
were combined and stripped to a residue of 17 ml, which was
filtered to remove the precipitated NH4Cl. Finally, the solvent
of the filtrate was evaporated.
[B]
[BH+
pH=pKa +log
]
where [B] is the concentration of deprotonated benzylammonium
and [BH+] is the concentration of benzylammonium.
10 R. Talhout and J. B. F. N. Engberts, Eur. J. Biochem., 2001, 268,
1554–1560.
11 S. Leavitt and E. Freire, Curr. Opin. Struct. Biol., 2001, 11, 560–
566.
12 C. T. Calderone and D. H. Williams, J. Am. Chem. Soc., 2001, 123,
6262–6267.
13 A. Cooper, C. M. Johnson, J. H. Lakey and M. Nöllmann, Biophys.
Chem., 2001, 93, 215–230.
14 J. D. Dunitz, Chem. Biol., 1995, 2, 709–712.
15 W. C. Conner, J. Catal., 2003, 78, 238–246.
16 S. W. Benson, Thermochemical Kinetics, Wiley: New York, 1968.
17 Structure-Based Drug Design: Thermodynamics, Modelling and
Strategy, ed. J. E. Ladbury, and P. R. Connelly, Springer: Berlin,
1997.
18 Protein–Ligand Interactions: Hydrodynamics and Calorimetry, eds.
S. E. Harding, and B. Z. Chowdry, Oxford University Press, Oxford,
2001.
19 W. Blokzijl and J. B. F. N. Engberts, Angew. Chem., Int. Ed. Engl.,
1993, 32, 1545–1579.
20 N. T. Southall, K. A. Dill and A. D. J. Haymet, J. Phys. Chem. B,
2002, 106, 521–533.
21 J. H. Ha, R. S. Spolar and M. T. Record, J. Mol. Biol., 1989, 209,
801–816.
22 C. Hansch; A. Leo in Exploring QSAR: Fundamentals and Applica-
tions in Chemistry and Biology, ed. S. R. Heller, ACS, Washington,
DC, 1995.
23 G. Graziano, Can. J. Chem., 2000, 78, 1233–1241.
24 W. P. Jencks, Catalysis in Chemistry and Enzymology, McGraw-Hill,
New York, 1969, pp. 393–436.
Scheme 1 Synthesis of cyclohexylcarboxamidinium chloride.
The crude product was purified by stirring overnight in 10 ml
of i-propanol, which was filtered to remove the precipitated
NH4Cl and the solvent of the filtrate was evaporated. To remove
organic contaminations, the product was dissolved in as little i-
propanol as possible and titrated in 300 ml of ether, from which
the precipitate was filtered off; this procedure was performed
twice. The product was washed with ether and n-hexane and sub-
sequently freeze-dried from 1 M hydrochloric acid to yield 1.8 g
(60%) of cyclohexylcarboxamidinium chloride,28 mp 181–182 °C
(dec., lit.28 184–185 °C). 1H-NMR (300 MHz, DMSO-d6, ppm):
8.92 (s, broad, 2H), 8.81 (s, broad, 2H), 2.44 (t, 1H, J = 12.3 Hz),
1.78–1.10 (m, 10H). Elemental analysis: calc: C 51.69% H 9.29%
N 17.22% found: C 51.63% H 9.43% N 17.23%.
25 M. J. Todd, I. Luque, A. Velásquez-Campoy and E. Freire, Biochem-
istry, 2000, 39, 11876–11883.
26 R. Talhout, A. Villa, A. E. Mark and J. B. F. N. Engberts, J. Am.
Chem. Soc., 2003, 125, 10570–10579.
27 R. A. Moss, W. Ma, D. C. Merrer and S. Xue, Tetrahedron Lett.,
1995, 36, 8761–8764.
28 H. Schubert, J. Prakt. Chem., 1956, 4, 146–152.
29 F. C. Bernstein, T. F. Koetzle, G. J. B. Williams, E. F. Jr. Meyer,
M. D. Brice, J. R. Rodgers, O. Kennard, T. Shimanouchi and
M. Tasumi, J. Mol. Biol., 1977, 112, 542.
References
1 F. P. Schmidtchen and M. Berger, Chem. Rev., 1997, 97, 1609–1646.
2 Proteinase Inhibitors, ed. A. J. Barrett and G. Salvesen, Elsevier,
Amsterdam, 1986.
3 M. Mares-Guia and E. Shaw, J. Biol. Chem., 1965, 240, 1579–1585.
4 W. Bode and P. Schwager, J. Mol. Biol., 1975, 98, 693–717.
5 M. Renatus, W. Bode, R. Huber, J. Stürzebecher and M. T. Stubbs, J.
Med. Chem., 1998, 41, 5445–5456.
6 T. Inagami, J. Biol. Chem., 1964, 239, 787–791.
7 N. Ota, C. Stroupe, J. M. S. Ferreira-da-Silva, S. A. Shah, M. Mares-
Guia and A. T. Brunger, Proteins, 1999, 37, 641–653.
30 R. A. Sayle and E. J. Milnerwhite, Trends Biochem. Sci., 1995, 20,
374–376.
3 0 7 4
O r g . B i o m o l . C h e m . , 2 0 0 4 , 2 , 3 0 7 1 – 3 0 7 4